The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 07, 2022
Filed:
Jul. 26, 2019
Applicant:
Ena Therapeutics Pty Ltd, Melbourne, AU;
Inventors:
Assignee:
ENA THERAPEUTICS PTY LTD, Melbourne, AU;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/02 (2006.01); A61K 39/04 (2006.01); A61K 47/60 (2017.01); A61K 39/39 (2006.01); A61K 9/00 (2006.01); A61K 38/06 (2006.01); A61K 38/07 (2006.01); A61K 38/08 (2019.01); C07K 7/06 (2006.01); A61K 31/23 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0043 (2013.01); A61K 31/23 (2013.01); A61K 38/06 (2013.01); A61K 38/07 (2013.01); A61K 38/08 (2013.01); A61K 39/39 (2013.01); A61K 47/60 (2017.08); C07K 7/06 (2013.01); C07K 2319/00 (2013.01); Y02A 50/30 (2018.01);
Abstract
This invention relates to a method for treating or preventing a disease by raising an innate immune response in a subject, the method comprising administering to the subject an effective amount of a composition comprising a TLR2 moiety in solution, wherein the TLR2 moiety comprises a TLR2 agonist and wherein the disease is not treated or prevented by a humoral or cellular immune response directed against the TLR2 moiety.